Targeting these modifications has shown promising results in the treatment for neurodegenerative diseases, especially concerning histone writers and erasers such as HAT and HDAC, respectively, and readers of histone acetylome such as the BET proteins (Table 1). Here, DNER is linked to neurodegenerative disease.